Wockhardt have discontinued glibenclamide tablets. They do not have any stock remaining. There are no other manufacturers in the market. This memo advises on switching to other sulfonylureas. If it is not considered appropriate to switch patients, unlicensed imports of glibenclamide tablets are available.